Pre Filled Syringes Global Market Report 2024

Pre-filled syringes refer to syringes that come pre-loaded with the substance intended for injection, facilitating the accurate delivery of the contents to the desired location.

The primary types of pre-filled syringes include conventional pre-filled syringes and safety pre-filled syringes. Conventional pre-filled syringes typically contain a single-dose packet of vaccines, with a manufacturer-fixed needle designed for one-time use. After application, the syringe is disposed of. Safety pre-filled syringes, on the other hand, contain a single-dose packet of vaccine intended for self-administration by patients who require regular injections in a home setting. Needles for these syringes are crafted from materials such as glass and plastic, and the syringes come in various forms, including single-chamber pre-filled syringes, dual-chamber pre-filled syringes, and customized pre-filled syringes. These pre-filled syringes find applications in a range of medical conditions such as diabetes, rheumatoid arthritis, anaphylaxis, cancer, thrombosis, ophthalmology, and others.

The pre-filled syringes market research report is one of a series of new reports that provides pre-filled syringes market statistics, including pre-filled syringes industry global market size, regional shares, competitors with a pre-filled syringes market share, detailed pre-filled syringes market segments, market trends and opportunities and any further data you may need to thrive in the pre-filled syringes industry. The pre-filled syringe market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pre filled syringes market size has grown rapidly in recent years. It will grow from $7.42 billion in 2023 to $8.51 billion in 2024 at a compound annual growth rate (CAGR) of 14.8%. The growth observed in the historical period can be attributed to factors such as the expansion of the pharmaceutical and biotechnology industry, the growth of biologics and vaccines, the demand for user-friendly and precise drug delivery methods, the increase in home healthcare and self-administration practices, and the establishment of regulatory standards emphasizing drug safety and packaging.

The pre filled syringes market size is expected to see rapid growth in the next few years. It will grow to $14.46 billion in 2028 at a compound annual growth rate (CAGR) of 14.2%. The anticipated growth in the forecast period can be attributed to several factors, including the development of customized pre-filled syringe solutions tailored for specific drugs, the expansion of biodegradable and sustainable materials in syringe manufacturing, innovation in connected and smart syringes, increased utilization in telemedicine and telehealth applications, and the growing adoption of long-acting injectable medications. Major trends expected in the forecast period encompass a focus on regulatory compliance to enhance safety in pre-filled syringes, the emergence of smart and connected syringes for precise dosing, the utilization of biodegradable and eco-friendly materials in syringe production, the provision of personalized syringe solutions for specific patient populations, and an emphasis on transparency and traceability in drug delivery processes.

The pre-filled syringe market is anticipated to experience significant growth due to the increasing prominence of home-based healthcare during the forecast period. Home-based healthcare involves providing medical treatment and support to patients in their residences, aiming to facilitate recovery, manage illnesses, and deliver care in the convenience of patients' homes. The pre-filled syringe market is poised for substantial expansion, aligning with the changing healthcare landscape by ensuring precise dosing, minimizing contamination risks, and enhancing patient compliance. This contributes to an elevated quality of care delivered within the comfort of patients' homes. For example, data from the National Association for Home Care and Hospice in February 2023 reveals that around 12 million Americans annually receive home healthcare, with this number expected to continue growing. Hence, the surge in home-based healthcare is anticipated to drive market growth in the forecast period.

The pre-filled syringes market is expected to witness a boost in demand due to the administration of COVID-19 vaccines, further driving growth during the forecast period. Pre-filled syringes are preferred for COVID-19 vaccine administration to mitigate the risk of needle stick infections. To meet the escalating demand for COVID-19 vaccinations, companies are focusing on scaling up the production of pre-filled syringes. For instance, as reported by PATH in November 2021, the anticipated increase in COVID-19 vaccine dosage supplies is projected to surpass $4 billion between late 2021 and mid-2022, addressing the global shortfall of 1.2 billion autodisable (AD) syringes. Consequently, the heightened demand for pre-filled syringes for COVID-19 vaccines is expected to foster market growth throughout the forecast period.

Companies operating in the pre-filled syringes market are increasingly investing in next-generation prefilled syringes, incorporating features that enable healthcare professionals to track and access data. Next-generation pre-filled syringes refer to technologically advanced syringes designed to enhance drug delivery, elevate patient safety, and provide additional features like connectivity and usability. In September 2022, Becton, Dickinson and Company (BD), a US-based medical technology company, introduced a next-generation glass prefillable syringe designed to meet rigorous standards for processability, cosmetics, integrity, and contamination. This innovative syringe, known as BD Effivax Glass Prefillable Syringe, was developed in collaboration with leading pharmaceutical companies to address the evolving requirements of vaccine production.

Leading healthcare companies in the pre-filled syringe market are seeking approval for innovative products, such as single-dose pre-filled syringes, to broaden their presence in the healthcare sector. Single-dose pre-filled syringes, which contain a disposable syringe preloaded with medication liquid for injection, offer a convenient solution for administering treatments. For example, in March 2023, the Food and Drug Administration (FDA) granted approval for Emerphed (ephedrine sulfate injection) in 25 mg/5 mL and 50 mg/10 mL single-dose pre-filled syringes manufactured by Nexus Pharmaceuticals Inc., a US-based pharmaceutical company. This marks the FDA's approval of the first 10-milliliter (mL) pre-filled syringe for ephedrine sulfate injection.

Major companies operating in the pre filled syringes market include Becton, Dickinson and Company, Gerresheimer AG, Schott & Associates Glass Technology Laboratory, West Pharmaceutical Services Inc., Baxter International, Nipro Corporation, Terumo Corporation, Vetter Pharma International GmbH, Stevanato Group SPA, Shandong Weigao Group Medical Polymer Company Ltd., Novartis AG, Catalent Inc., Unilife Corporation, Eli Lilly and Company, Applied Molecular Genetics Inc., Bayer AG, Pfizer Inc., Bristol-Myers Squibb Co., F. Hoffman-La Roche Ltd., AbbVie Inc., Owen Mumford Holdings Ltd., AptarGroup Inc., Medtronic PLC, Abbott Laboratories, Fresenius Kabi India Pvt. Ltd., Medical Protective Ltd., Mylan NV, Elcam Medical Inc., YPSOMED Holding AG, Oval Medical Technologies, SHL Medical, ACASI Machinery Inc., Bespak Holdings Ltd., BioPharma Solutions, Catalent Pharma Solutions, Credence MedSystems Inc., Hasemeier Inc., Intas Pharmaceuticals Ltd., Intelicure Lifesciences, Mycoscience Labs

Europe was the largest region in the prefilled syringes market in 2023. The regions covered in the prefilled syringes market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the pre-filled syringes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

The pre-filled syringes market consists of sales of glass prefilled syringes and plastic prefilled syringes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.